Mammalian Genome

, Volume 17, Issue 8, pp 808–821 | Cite as

Analysis of expansion of myeloid progenitors in mice to identify leukemic susceptibility genes

  • Vincent E. Sollars
  • Ed Pequignot
  • Jay L. Rothstein
  • Arthur M. Buchberg
Original Contributions


The myeloid progenitor cell compartment (MPC) exhibits pronounced expansion in human myeloid leukemias. It is becoming more apparent that progression of myelodysplastic syndromes and myeloproliferative diseases to acute myelogenous leukemia is the result of defects in progenitor cell maturation. The MPC of bone marrow was analyzed in mice using a cell culture assay for measuring the relative frequency of proliferative myeloid progenitors. Response to the cytokines SCF, IL-3, and GM-CSF was determined by this assay for the leukemic mouse strain BXH-2 and ten other inbred mouse strains. Significant differences were found to exist among ten inbred mouse strains in the nature of their MPC in bone marrow, indicating the presence of genetic polymorphisms responsible for the divergence. The SWR/J and FVB/J strains show consistently low frequencies of myeloid progenitors, while the DBA/2J and SJL/J inbred strains show consistently high frequencies of myeloid progenitors within the bone marrow compartment. In addition, in silico linkage disequilibrium analysis was conducted to identify possible chromosomal regions responsible for the phenotypic variation. Given the importance of this cell compartment in leukemia progression and the soon to be released genomic sequence of 15 mouse strains, these differences may provide a valuable tool for research into leukemia.


Quantitative Trait Locus Analysis Inbred Strain Acute Myelogenous Leukemia Stem Cell Factor Myeloid Progenitor 



The authors thank Jonathan D. Smith from the Lerner Research Institute for his generous donation of a formatted SNP database. They acknowledge Dr. Linda Siracusa and Dr. Walter Hauck for critical review of this manuscript. This work was supported in part by grants from the NCI. VES was supported in part by NIH training grant T32-CA09678. Some supplies were supplied by a March of Dimes research grant (658).


  1. Bedigian HG, Taylor BA, Meier H (1981) Expression of murine leukemia viruses in the highly lymphomatous BXH-2 recombinant inbred mouse strain. J Virol 39: 632–640PubMedGoogle Scholar
  2. Bedigian HG, Johnson DA, Jenkins NA, Copeland NG, Evans R (1984) Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol 51: 586–594PubMedGoogle Scholar
  3. Briddell RA, Hartley CA, Smith KA, McNiece IK (1993) Recombinant rat stem cell factor synergizes with recombinant human granulocyte colony-stimulating factor in vivo in mice to mobilize peripheral blood progenitor cells that have enhanced repopulating potential. Blood 82: 1720–1723PubMedGoogle Scholar
  4. Castor A, Nilsson L, Astrand-Grundstrom I, Buitenhuis M, Ramirez C, et al. (2005) Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia. Nat Med 11: 630–637PubMedCrossRefGoogle Scholar
  5. Champion K M, Gilbert JG, Asimakopoulos FA, Hinshelwood S, Green AR (1997) Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. Br J Haematol 97: 920–926PubMedCrossRefGoogle Scholar
  6. Chen J, Harrison DE (2002) Quantitative trait loci regulating relative lymphocyte proportions in mouse peripheral blood. Blood 99: 561–566PubMedCrossRefGoogle Scholar
  7. Chen J, Astle CM, Harrison DE (1999) Development and aging of primitive hematopoietic stem cells in BALB/cBy mice. Exp Hematol 27: 928–935PubMedCrossRefGoogle Scholar
  8. Chen J, Astle CM, Harrison DE (2000) Genetic regulation of primitive hematopoietic stem cell senescence. Exp Hematol 28: 442–450PubMedCrossRefGoogle Scholar
  9. Christensen K, Kristiansen M, Hagen-Larsen H, Skytthe A, Bathum L, et al. (2000) X-linked genetic factors regulate hematopoietic stem-cell kinetics in females. Blood 95: 2449–2451PubMedGoogle Scholar
  10. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W (1994) Current Protocols in Immunology In: Current Protocols, Coico R (ed.) (New York: John Wiley & Sons), pp 5.3.1–5.3.7Google Scholar
  11. Crump WL 3rd, Owen-Schaub LB, Grimm EA (1989) Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells. Cancer Res 49: 149–153PubMedGoogle Scholar
  12. de Haan G, Van Zant G (1997) Intrinsic and extrinsic control of hemopoietic stem cell numbers: mapping of a stem cell gene. J Exp Med 186: 529–536PubMedCrossRefGoogle Scholar
  13. de Haan G, Van Zant G (1999a) Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 93: 3294–3301Google Scholar
  14. de Haan G, Van Zant G (1999b) Genetic analysis of hemopoietic cell cycling in mice suggests its involvement in organismal life span. FASEB J 13: 707–713Google Scholar
  15. de Haan G, Nijhof W, Van Zant G (1997) Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 89: 1543–1550PubMedGoogle Scholar
  16. Feinberg AP, Ohlsson R, Henikoff S (2006) The epigenetic progenitor origin of human cancer. Nat Rev Genet 7: 21–33PubMedCrossRefGoogle Scholar
  17. Finkelman FD, Holmes J, Katona IM, Urban JF Jr, Beckmann MP, et al. (1990) Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 8: 303–333PubMedCrossRefGoogle Scholar
  18. Grupe A, Germer S, Usuka J, Aud D, Belknap JK, et al. (2001) In silico mapping of complex disease-related traits in mice. Science 292: 1915–1918PubMedCrossRefGoogle Scholar
  19. Hara T, Ichihara M, Takagi M, Miyajima A (1995) Interleukin-3 (IL-3) poor-responsive inbred mouse strains carry the identical deletion of a branch point in the IL-3 receptor alpha subunit gene. Blood 85: 2331–2336PubMedGoogle Scholar
  20. Henckaerts E, Geiger H, Langer JC, Rebollo P, Van Zant G, et al. (2002) Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines. Blood 99: 3947–3954PubMedCrossRefGoogle Scholar
  21. Hoffmann MK, Gilbert KM, Hirst JA, Scheid M (1987) An essential role for interleukin 1 and a dual function for interleukin 2 in the immune response of murine B lymphocytes to sheep erythrocytes. J Mol Cell Immunol 3: 29–36PubMedGoogle Scholar
  22. Hommel G, Krummenauer F (1998) Improvements and modifications of Tarone’s multiple test procedure for discrete data. Biometrics 54: 673–681CrossRefGoogle Scholar
  23. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, et al. (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351: 657–667PubMedCrossRefGoogle Scholar
  24. Jandl JH (1996) Blood cell formation. In: Blood: Textbook of Hematology (Boston: Little, Brown), pp 1–55Google Scholar
  25. Jenkins NA, Copeland NG, Taylor BA, Bedigian HG, Lee BK (1982) Ecotropic murine leukemia virus DNA content of normal and lymphomatous tissues of BXH-2 recombinant inbred mice. J Virol 42: 379–388PubMedGoogle Scholar
  26. Kile BT, Mason-Garrison CL, Justice MJ (2003) Sex and strain-related differences in the peripheral blood cell values of inbred mouse strains. Mamm Genome 14: 81–85PubMedCrossRefGoogle Scholar
  27. Li J, Shen H, Himmel KL, Dupuy AJ, Largaespada DA, et al. (1999) Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet 23: 348–353PubMedCrossRefGoogle Scholar
  28. Male D (1998) Cell Migration and Inflamation. In: Immunology, Roitt I, Brostoff J, Male D (eds.) (St. Louis: C.V. Mosby) pp 61–69Google Scholar
  29. Metcalf D, Mifsud S, Di Rago L (2002) Stem cell factor can stimulate the formation of eosinophils by two types of murine eosinophil progenitor cells. Stem Cells 20: 460–469PubMedCrossRefGoogle Scholar
  30. Molineux G, Migdalska A, Szmitkowski M, Zsebo K, Dexter TM (1991) The effects on hematopoiesis of recombinant stem cell factor (ligand for c-kit) administered in vivo to mice either alone or in combination with granulocyte colony-stimulating factor. Blood 78: 961–966PubMedGoogle Scholar
  31. Mucenski ML, Bedigian HG, Shull MM, Copeland NG, Jenkins NA (1988) Comparative molecular genetic analysis of lymphomas from six inbred mouse strains. J Virol 62: 839–846PubMedGoogle Scholar
  32. Muller-Sieburg CE, Riblet R (1996) Genetic control of the frequency of hematopoietic stem cells in mice: mapping of a candidate locus to chromosome 1. J Exp Med 183: 1141–1150PubMedCrossRefGoogle Scholar
  33. Muller-Sieburg CE, Cho RH, Sieburg HB, Kupriyanov S, Riblet R (2000) Genetic control of hematopoietic stem cell frequency in mice is mostly cell autonomous. Blood 95: 2446–2448PubMedGoogle Scholar
  34. Okamoto K, Yamada Y, Ogawa MS, Toyokuni S, Nakakuki Y, et al. (1994) Abnormal bone marrow B-cell differentiation in pre-B lymphoma-prone SL/Kh mice. Cancer Res 54: 399–402PubMedGoogle Scholar
  35. Peters LL, Cheever EM, Ellis HR, Magnani PA, Svenson KL, et al. (2002) Large-scale, high-throughput screening for coagulation and hematologic phenotypes in mice. Physiol Genomics 11: 185–193PubMedGoogle Scholar
  36. Pletcher MT, McClurg P, Batalov S, Su AI, Barnes SW, et al. (2004) Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. PLoS Biol 2: e393PubMedCrossRefGoogle Scholar
  37. Roberts AW, Foote S, Alexander WS, Scott C, Robb L, et al. (1997) Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 89: 2736–2744PubMedGoogle Scholar
  38. Rook G (1996) Cell-mediated immune reactions. In: Immunology, Riott I, Brostoff J, Male D (eds.) (St. Louis: C.V. Mosby), pp 9.1–9.15Google Scholar
  39. Smith JD, James D, Dansky HM, Wittkowski KM, Moore KJ, et al. (2003) In silico quantitative trait locus map for atherosclerosis susceptibility in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23: 117–122PubMedCrossRefGoogle Scholar
  40. Terskikh AV, Miyamoto T, Chang C, Diatchenko L, Weissman IL (2003) Gene expression analysis of purified hematopoietic stem cells and committed progenitors. Blood 102: 94–101PubMedCrossRefGoogle Scholar
  41. Turcotte K, Gauthier S, Mitsos LM, Shustik C, Copeland NG, et al. (2004) Genetic control of myeloproliferation in BXH-2 mice. Blood 103: 2343–2350PubMedCrossRefGoogle Scholar
  42. Turcotte K, Gauthier S, Tuite A, Mullick A, Malo D, et al. (2005) A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice. J Exp Med 201: 881–890PubMedCrossRefGoogle Scholar
  43. Van Zant G, Eldridge PW, Behringer RR, Dewey MJ (1983) Genetic control of hematopoietic kinetics revealed by analyses of allophenic mice and stem cell suicide. Cell 35: 639–645PubMedCrossRefGoogle Scholar
  44. Vickers MA, McLeod E, Spector TD, Wilson IJ (2001) Assessment of mechanism of acquired skewed X inactivation by analysis of twins. Blood 97: 1274–1281PubMedCrossRefGoogle Scholar
  45. Yasuhiro A, Sugimoto K, Sato AK, Mori KJ (2002) Identification of negative regulator of interleukin-3 (NIL-3) in bone marrow. Cell Struct Funct 27: 81–89PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Vincent E. Sollars
    • 1
    • 4
  • Ed Pequignot
    • 2
  • Jay L. Rothstein
    • 3
  • Arthur M. Buchberg
    • 1
  1. 1.Department of Microbiology and Immunology, Kimmel Cancer CenterThomas Jefferson UniversityPhiladelphiaUSA
  2. 2.Department of Medicine, Division of Clinical Pharmacology, Kimmel Cancer CenterThomas Jefferson UniversityPhiladelphiaUSA
  3. 3.Department of Otolaryngology-Head and Neck Surgery, Kimmel Cancer CenterThomas Jefferson UniversityPhiladelphiaUSA
  4. 4.Department of Microbiology, Immunology, and Molecular GeneticsJoan C. Edwards School of Medicine, Marshall UniversityHuntingtonUSA

Personalised recommendations